Synthesis and characterization of polyethylene glycol coated magnetic nanoparticles and their use for anti-cancer drug delivery

Erdem, Murat
Although conventional chemotherapy is the most valid method to cope with cancer, it has many drawbacks such as decrease in production of blood cells, inflammation of the lining of the digestive tract, hair loss etc. Reasons for its side effects are that drugs used in chemotherapy are distributed evenly within the body of a patient and cannot distinguish the cancer cells from the healthy ones. To decrease the negative effects of chemotherapeutic drugs and to increase their efficiency, many drug delivery systems have been developed until now. Magnetic nanoparticles have an important potential for cancer treatment. The most significant feature of magnetic nanoparticles is that they can be manipulated for targeting to tumor side by application of external magnetic field. Also, their small size and their capability to carry drug by surface modification are other important characteristics for drug delivery. Aim of this study is to synthesize folic acid conjugated, polyethylene coated magnetic nanoparticles (FA-MNPs) and doxorubicin loaded formulation (Dox-FA-MNPs), and to vi investigate their cytotoxicity on HeLa and doxorubicin resistant HeLa cells. Magnetic nanoparticles (MNPs), PEG coated MNPs and FA-MNPs were successfully synthesized and characterized by one or more of TEM, FTIR, XRD, TGA and VSM analysis. Doxorubicin (Dox) loading capacity of FA-MNPs and release profile of Dox from Dox-FA-MNPs were investigated by spectrometer. Internalization of FA-MNPs and Dox-FA-MNPs by HeLa cells were observed by purssian blue staining under light microscopy and by using fluorescent property of Dox under fluorescent microscopy respectively. Biocompatibility of FA-MNPs and antiproliferative effects of Dox-FA-MNPs on HeLa and HeLa/Dox cells were analyzed by XTT cell proliferation assay. The results show that synthesis of MNPs, PEG-MNPs and FA-MNPs were successfully achieved. MNPs had a special shape and small size and also had supermagnetic behavior. 505 μM of 1724 μM Dox was loaded 500 μg/mL FA-MNPs and in 24 h, 68,35 μM Dox was released from 500 μg/mL Dox-FA-MNPs. Also, drug release was increased in acidic condition from Dox-FA-MNPs. Internalization experiments showed that FA-MNPs and Dox-FA-MNPs were taken up by HeLa cells. FA-MNPs and Dox-FA-MNPs were given to HeLa and HeLa/Dox cells for investigation of their cytotoxicities. Cell proliferation assay results showed that Dox-FA-MNPs significantly decreased the proliferation of HeLa cells when compared to FA-MNPs. However, Dox-FA-MNPs did not show same effects on HeLa/Dox cells. Despite that Dox-FA-MNPs could not overcome drug resistance of HeLa/Dox cells, they effectively killed HeLa cells. As a result, FA-MNPs have found to be important for carrying Dox.


Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery
Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Targeted co-delivery of doxorubicin and TPGS to breast cancer cells by PLGA coated magnetic nanoparticles
Metin, Esra; Gündüz, Ufuk; Mutlu, Pelin; Department of Biotechnology (2017)
Although conventional chemotherapy is the most common method for cancer treatment, it has several side effects such as neuropathy, alopecia and cardiotoxicity. Since the drugs are given to body systemically, normal cells also effect as cancer cells. However, in recent years, targeted drug delivery has been developed to overcome these drawbacks.The targeting strategy can be changed depending on carrier types, but magnetic nanoparticles are commonly preferred due to their easy targetable features by using ext...
Synthesis and characterization of polymeric magnetic nanoparticles loaded by gemcitabine /
Parsian, Maryam; Gündüz, Ufuk; Tezcaner, Ayşen; Department of Biotechnology (2014)
In this study, different types of magnetic nanoparticles were synthesized for treatment of breast cancer by targeted drug delivery. Polyamidoamine (PAMAM) dendrimer, Chitosan (CS) and Polyhydroxybutyrate (PHB) coated magnetic nanoparticles were prepared and loaded with Gemcitabine. The loading efficiency of drug for various half generations of dendrimer coated magnetic nanoparticles (DcMNPs), Chitosan coated magnetic nanoparticles (CSMNPs) and Polyhydroxybutyrate magnetic nanoparticles (PHB-MNPs) were inves...
Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer
Gündüz, Ufuk; Tansik, Gulistan; Mutlu, Pelin; Unsoy, Gozde; YAKAR, ARZU; Khodadust, Rouhollah; Gunduz, Gungor (2014-07-01)
Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. Another major problem is the drug resistance development before or during the treatment. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings. The studies aim targeted drug delivery to tumor site. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be target...
Monoclonal antibodies for targeted therapy in colorectal cancer.
Banerjee, Sreeparna (Informa UK Limited, 2010-04-15)
Traditional therapeutic regimens of solid tumors such as chemotherapy and radiotherapy often do not distinguish between malignant and normal tissues, resulting in considerable side-effects. Monoclonal antibodies (mAbs), targeted against antigens dysregulated in cancers, have therefore generated great interest in both clinical and research settings. The antibodies are either chimeric or human(ized) and can bind to and inhibit target proteins overexpressed in both solid tumors and hematological malignancies. ...
Citation Formats
M. Erdem, “Synthesis and characterization of polyethylene glycol coated magnetic nanoparticles and their use for anti-cancer drug delivery,” M.S. - Master of Science, Middle East Technical University, 2014.